Požymis
Headache
Cephalgia, or pain sensed in various parts of the head, not confined to the area of distribution of any nerve.
Santrauka
- Taip pat vadinama
- Headaches
- Kūno sistema
- Abnormality of the nervous system
Atskaitos genomasGRCh38hg38
Pozicijos genų ir variantų puslapiuose rodomos pagal šį pasirinkimą šioje naršyklėje.
Read the genes linked to Headache, and the rest of your genome, with one test.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites
Įsigyti savo Genome Test265 genų susiję su Headache
Šių genų pakitimai sukelia retas ligas, kuriose pasireiškia Headache. Dauguma žmonių, turinčių šį požymį, neturi nė vienos iš tų ligų, o šiame sąraše esantis genas nieko nesako apie kieno nors paties genomą.
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| BCAT2branched chain amino acid transaminase 2 | Visada | 1 ligoje |
| CST3cystatin C | Visada | 1 ligoje |
| FARSBphenylalanyl-tRNA synthetase subunit beta | Visada | 1 ligoje |
| KLklotho | Visada | 1 ligoje |
| LIG3DNA ligase 3 | Visada | 1 ligoje |
| LRRC7leucine rich repeat containing 7 | Visada | 1 ligoje |
| LYNLYN proto-oncogene, Src family tyrosine kinase | Visada | 1 ligoje |
| MCATmalonyl-CoA-acyl carrier protein transacylase | Visada | 1 ligoje |
| MECRmitochondrial trans-2-enoyl-CoA reductase | Visada | 2 ligose |
| NLRP3NLR family pyrin domain containing 3 | Visada | 4 ligose |
| PIGTphosphatidylinositol glycan anchor biosynthesis class T | Visada | 1 ligoje |
| POLG2DNA polymerase gamma 2, accessory subunit | Visada | 1 ligoje |
| RRP12ribosomal RNA processing 12 homolog | Visada | 2 ligose |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Visada | 2 ligose |
| SLC25A4solute carrier family 25 member 4 | Visada | 1 ligoje |
| SOSTsclerostin | Visada | 3 ligose |
| TNFRSF11ATNF receptor superfamily member 11a | Visada | 1 ligoje |
| TOP2BDNA topoisomerase II beta | Visada | 1 ligoje |
| VHLvon Hippel-Lindau tumor suppressor | Visada | 2 ligose |
| ADA2adenosine deaminase 2 | Labai dažnai (80–99%) | 3 ligose |
| APPamyloid beta precursor protein | Labai dažnai (80–99%) | 1 ligoje |
| CCM2CCM2 scaffold protein | Labai dažnai (80–99%) | 3 ligose |
| DKK1dickkopf Wnt signaling pathway inhibitor 1 | Labai dažnai (80–99%) | 1 ligoje |
| ELANEelastase, neutrophil expressed | Labai dažnai (80–99%) | 1 ligoje |
| EPORerythropoietin receptor | Labai dažnai (80–99%) | 2 ligose |
| FASFas cell surface death receptor | Labai dažnai (80–99%) | 3 ligose |
| HLA-Bmajor histocompatibility complex, class I, B | Labai dažnai (80–99%) | 3 ligose |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Labai dažnai (80–99%) | 2 ligose |
| JAK2Janus kinase 2 | Labai dažnai (80–99%) | 4 ligose |
| KRIT1KRIT1 ankyrin repeat containing | Labai dažnai (80–99%) | 2 ligose |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Labai dažnai (80–99%) | 1 ligoje |
| PDCD10programmed cell death 10 | Labai dažnai (80–99%) | 3 ligose |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Labai dažnai (80–99%) | 2 ligose |
| PTENphosphatase and tensin homolog | Labai dažnai (80–99%) | 1 ligoje |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Labai dažnai (80–99%) | 3 ligose |
| SLC19A2solute carrier family 19 member 2 | Labai dažnai (80–99%) | 1 ligoje |
| AIPAHR interacting HSP90 co-chaperone | Dažnai (30–79%) | 2 ligose |
| AKT1AKT serine/threonine kinase 1 | Dažnai (30–79%) | 1 ligoje |
| ASXL1ASXL transcriptional regulator 1 | Dažnai (30–79%) | 1 ligoje |
| BAP1BRCA1 associated deubiquitinase 1 | Dažnai (30–79%) | 1 ligoje |
Rodyti dar 225 genų
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Dažnai (30–79%) | 3 ligose |
| C1Rcomplement C1r | Dažnai (30–79%) | 1 ligoje |
| C1Scomplement C1s | Dažnai (30–79%) | 1 ligoje |
| C4Acomplement C4A (Chido/Rodgers blood group) | Dažnai (30–79%) | 1 ligoje |
| CALRcalreticulin | Dažnai (30–79%) | 1 ligoje |
| CCR1C-C motif chemokine receptor 1 | Dažnai (30–79%) | 1 ligoje |
| CD46CD46 molecule | Dažnai (30–79%) | 1 ligoje |
| CDH23cadherin related 23 | Dažnai (30–79%) | 3 ligose |
| CFHcomplement factor H | Dažnai (30–79%) | 1 ligoje |
| CFIcomplement factor I | Dažnai (30–79%) | 1 ligoje |
| CLCN2chloride voltage-gated channel 2 | Dažnai (30–79%) | 2 ligose |
| CMPK2cytidine/uridine monophosphate kinase 2 | Dažnai (30–79%) | 1 ligoje |
| CPT2carnitine palmitoyltransferase 2 | Dažnai (30–79%) | 1 ligoje |
| CTNNB1catenin beta 1 | Dažnai (30–79%) | 1 ligoje |
| EPM2AEPM2A glucan phosphatase, laforin | Dažnai (30–79%) | 1 ligoje |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Dažnai (30–79%) | 1 ligoje |
| GCDHglutaryl-CoA dehydrogenase | Dažnai (30–79%) | 1 ligoje |
| GDF3growth differentiation factor 3 | Dažnai (30–79%) | 1 ligoje |
| GDF6growth differentiation factor 6 | Dažnai (30–79%) | 1 ligoje |
| GNAQG protein subunit alpha q | Dažnai (30–79%) | 1 ligoje |
| GPR101G protein-coupled receptor 101 | Dažnai (30–79%) | 2 ligose |
| HELLPARHELLP associated long non-coding RNA | Dažnai (30–79%) | 1 ligoje |
| IFNGR1interferon gamma receptor 1 | Dažnai (30–79%) | 1 ligoje |
| IL10interleukin 10 | Dažnai (30–79%) | 1 ligoje |
| IL12Ainterleukin 12A | Dažnai (30–79%) | 1 ligoje |
| IL12A-AS1IL12A antisense RNA 1 | Dažnai (30–79%) | 1 ligoje |
| IL12Binterleukin 12B | Dažnai (30–79%) | 1 ligoje |
| IL23Rinterleukin 23 receptor | Dažnai (30–79%) | 1 ligoje |
| IRF3interferon regulatory factor 3 | Dažnai (30–79%) | 1 ligoje |
| JAM2junctional adhesion molecule 2 | Dažnai (30–79%) | 1 ligoje |
| KCNA1potassium voltage-gated channel subfamily A member 1 | Dažnai (30–79%) | 2 ligose |
| KITKIT proto-oncogene, receptor tyrosine kinase | Dažnai (30–79%) | 2 ligose |
| KLRC4killer cell lectin like receptor C4 | Dažnai (30–79%) | 1 ligoje |
| KYNUkynureninase | Dažnai (30–79%) | 1 ligoje |
| LPIN2lipin 2 | Dažnai (30–79%) | 1 ligoje |
| LRP6LDL receptor related protein 6 | Dažnai (30–79%) | 1 ligoje |
| MEFVMEFV innate immunity regulator, pyrin | Dažnai (30–79%) | 2 ligose |
| MEN1menin 1 | Dažnai (30–79%) | 2 ligose |
| MEOX1mesenchyme homeobox 1 | Dažnai (30–79%) | 1 ligoje |
| MLXMAX dimerization protein MLX | Dažnai (30–79%) | 1 ligoje |
| MPLMPL proto-oncogene, thrombopoietin receptor | Dažnai (30–79%) | 2 ligose |
| MRPS2mitochondrial ribosomal protein S2 | Dažnai (30–79%) | 1 ligoje |
| MT-ATP6mitochondrially encoded ATP synthase membrane subunit 6 | Dažnai (30–79%) | 1 ligoje |
| MVKmevalonate kinase | Dažnai (30–79%) | 1 ligoje |
| MYORGmyogenesis regulating glycosidase | Dažnai (30–79%) | 1 ligoje |
| NAA60N-alpha-acetyltransferase 60, NatF catalytic subunit | Dažnai (30–79%) | 1 ligoje |
| NF1neurofibromin 1 | Dažnai (30–79%) | 2 ligose |
| NF2NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor | Dažnai (30–79%) | 2 ligose |
| NFE2L2NFE2 like bZIP transcription factor 2 | Dažnai (30–79%) | 1 ligoje |
| NHLRC1NHL repeat containing E3 ubiquitin protein ligase 1 | Dažnai (30–79%) | 1 ligoje |
| NLRP12NLR family pyrin domain containing 12 | Dažnai (30–79%) | 1 ligoje |
| NOTCH3notch receptor 3 | Dažnai (30–79%) | 1 ligoje |
| PDGFBplatelet derived growth factor subunit B | Dažnai (30–79%) | 2 ligose |
| PDGFRBplatelet derived growth factor receptor beta | Dažnai (30–79%) | 1 ligoje |
| PFN1profilin 1 | Dažnai (30–79%) | 1 ligoje |
| PIGAphosphatidylinositol glycan anchor biosynthesis class A | Dažnai (30–79%) | 1 ligoje |
| POLGDNA polymerase gamma, catalytic subunit | Dažnai (30–79%) | 1 ligoje |
| RYR1ryanodine receptor 1 | Dažnai (30–79%) | 1 ligoje |
| SH2B3SH2B adaptor protein 3 | Dažnai (30–79%) | 2 ligose |
| SLC20A2solute carrier family 20 member 2 | Dažnai (30–79%) | 1 ligoje |
| SLC2A1solute carrier family 2 member 1 | Dažnai (30–79%) | 4 ligose |
| SLC39A14solute carrier family 39 member 14 | Dažnai (30–79%) | 1 ligoje |
| SMAD3SMAD family member 3 | Dažnai (30–79%) | 1 ligoje |
| SMARCAL1SNF2 related chromatin remodeling annealing helicase 1 | Dažnai (30–79%) | 1 ligoje |
| SMARCB1SWI/SNF related BAF chromatin remodeling complex subunit B1 | Dažnai (30–79%) | 1 ligoje |
| SMARCE1SWI/SNF related BAF chromatin remodeling complex subunit E1 | Dažnai (30–79%) | 1 ligoje |
| SMOsmoothened, frizzled class receptor | Dažnai (30–79%) | 1 ligoje |
| SRSF2serine and arginine rich splicing factor 2 | Dažnai (30–79%) | 1 ligoje |
| STAT4signal transducer and activator of transcription 4 | Dažnai (30–79%) | 2 ligose |
| SUFUSUFU negative regulator of hedgehog signaling | Dažnai (30–79%) | 1 ligoje |
| TBK1TANK binding kinase 1 | Dažnai (30–79%) | 1 ligoje |
| TERTtelomerase reverse transcriptase | Dažnai (30–79%) | 1 ligoje |
| TET2tet methylcytosine dioxygenase 2 | Dažnai (30–79%) | 2 ligose |
| THPOthrombopoietin | Dažnai (30–79%) | 1 ligoje |
| TICAM1TIR domain containing adaptor molecule 1 | Dažnai (30–79%) | 1 ligoje |
| TLR3toll like receptor 3 | Dažnai (30–79%) | 1 ligoje |
| TLR4toll like receptor 4 | Dažnai (30–79%) | 1 ligoje |
| TLR7toll like receptor 7 | Dažnai (30–79%) | 1 ligoje |
| TNFRSF1ATNF receptor superfamily member 1A | Dažnai (30–79%) | 1 ligoje |
| TP53tumor protein p53 | Dažnai (30–79%) | 3 ligose |
| TRAF3TNF receptor associated factor 3 | Dažnai (30–79%) | 1 ligoje |
| TRAF7TNF receptor associated factor 7 | Dažnai (30–79%) | 1 ligoje |
| TRANK1tetratricopeptide repeat and ankyrin repeat containing 1 | Dažnai (30–79%) | 1 ligoje |
| UBAC2UBA domain containing 2 | Dažnai (30–79%) | 1 ligoje |
| UNC93B1unc-93B1 regulator of TLR signaling | Dažnai (30–79%) | 1 ligoje |
| VSX1visual system homeobox 1 | Dažnai (30–79%) | 1 ligoje |
| XPR1xenotropic and polytropic retrovirus receptor 1 | Dažnai (30–79%) | 1 ligoje |
| ACP5acid phosphatase 5, tartrate resistant | Kartais (5–29%) | 1 ligoje |
| ACTA1actin alpha 1, skeletal muscle | Kartais (5–29%) | 1 ligoje |
| ACTN4actinin alpha 4 | Kartais (5–29%) | 1 ligoje |
| ADARadenosine deaminase RNA specific | Kartais (5–29%) | 1 ligoje |
| ADRA2Badrenoceptor alpha 2B | Kartais (5–29%) | 1 ligoje |
| ALKALK receptor tyrosine kinase | Kartais (5–29%) | 1 ligoje |
| ALX4ALX homeobox 4 | Kartais (5–29%) | 1 ligoje |
| AMER1APC membrane recruitment protein 1 | Kartais (5–29%) | 1 ligoje |
| ANKFY1ankyrin repeat and FYVE domain containing 1 | Kartais (5–29%) | 1 ligoje |
| ANLNanillin, actin binding protein | Kartais (5–29%) | 1 ligoje |
| AP2S1adaptor related protein complex 2 subunit sigma 1 | Kartais (5–29%) | 1 ligoje |
| APOL1apolipoprotein L1 | Kartais (5–29%) | 1 ligoje |
| ARHGAP24Rho GTPase activating protein 24 | Kartais (5–29%) | 1 ligoje |
| ARHGDIARho GDP dissociation inhibitor alpha | Kartais (5–29%) | 1 ligoje |
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Kartais (5–29%) | 1 ligoje |
| ATP1A3ATPase Na+/K+ transporting subunit alpha 3 | Kartais (5–29%) | 1 ligoje |
| ATRXATRX chromatin remodeler | Kartais (5–29%) | 1 ligoje |
| AVILadvillin | Kartais (5–29%) | 1 ligoje |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Kartais (5–29%) | 1 ligoje |
| CACNA1Dcalcium voltage-gated channel subunit alpha1 D | Kartais (5–29%) | 1 ligoje |
| CBLIFcobalamin binding intrinsic factor | Kartais (5–29%) | 1 ligoje |
| CCND1cyclin D1 | Kartais (5–29%) | 1 ligoje |
| CD2APCD2 associated protein | Kartais (5–29%) | 1 ligoje |
| CDC73cell division cycle 73 | Kartais (5–29%) | 2 ligose |
| CDKN1Bcyclin dependent kinase inhibitor 1B | Kartais (5–29%) | 1 ligoje |
| CDKN2Bcyclin dependent kinase inhibitor 2B | Kartais (5–29%) | 1 ligoje |
| CNNM2cyclin and CBS domain divalent metal cation transport mediator 2 | Kartais (5–29%) | 1 ligoje |
| CNTN2contactin 2 | Kartais (5–29%) | 1 ligoje |
| COL4A3collagen type IV alpha 3 chain | Kartais (5–29%) | 1 ligoje |
| COQ8Bcoenzyme Q8B | Kartais (5–29%) | 1 ligoje |
| CORINcorin, serine peptidase | Kartais (5–29%) | 1 ligoje |
| CRB2crumbs cell polarity complex component 2 | Kartais (5–29%) | 1 ligoje |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Kartais (5–29%) | 1 ligoje |
| CTNND2catenin delta 2 | Kartais (5–29%) | 1 ligoje |
| CYP11B1cytochrome P450 family 11 subfamily B member 1 | Kartais (5–29%) | 1 ligoje |
| CYP11B2cytochrome P450 family 11 subfamily B member 2 | Kartais (5–29%) | 1 ligoje |
| DAAM2dishevelled associated activator of morphogenesis 2 | Kartais (5–29%) | 1 ligoje |
| EMP2epithelial membrane protein 2 | Kartais (5–29%) | 1 ligoje |
| F8coagulation factor VIII | Kartais (5–29%) | 2 ligose |
| FGFR2fibroblast growth factor receptor 2 | Kartais (5–29%) | 2 ligose |
| FGFR3fibroblast growth factor receptor 3 | Kartais (5–29%) | 1 ligoje |
| FLI1Fli-1 proto-oncogene, ETS transcription factor | Kartais (5–29%) | 1 ligoje |
| FLT1fms related receptor tyrosine kinase 1 | Kartais (5–29%) | 1 ligoje |
| GAPVD1GTPase activating protein and VPS9 domains 1 | Kartais (5–29%) | 1 ligoje |
| GBA1glucosylceramidase beta 1 | Kartais (5–29%) | 1 ligoje |
| GNB2G protein subunit beta 2 | Kartais (5–29%) | 1 ligoje |
| HACD13-hydroxyacyl-CoA dehydratase 1 | Kartais (5–29%) | 1 ligoje |
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Kartais (5–29%) | 1 ligoje |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Kartais (5–29%) | 1 ligoje |
| HTRA1HtrA serine peptidase 1 | Kartais (5–29%) | 1 ligoje |
| IFIH1interferon induced with helicase C domain 1 | Kartais (5–29%) | 1 ligoje |
| INF2inverted formin 2 | Kartais (5–29%) | 1 ligoje |
| IRAK1interleukin 1 receptor associated kinase 1 | Kartais (5–29%) | 1 ligoje |
| ITGA7integrin subunit alpha 7 | Kartais (5–29%) | 1 ligoje |
| KANK2KN motif and ankyrin repeat domains 2 | Kartais (5–29%) | 1 ligoje |
| KCNJ5potassium inwardly rectifying channel subfamily J member 5 | Kartais (5–29%) | 1 ligoje |
| KCNQ2potassium voltage-gated channel subfamily Q member 2 | Kartais (5–29%) | 1 ligoje |
| KIF23kinesin family member 23 | Kartais (5–29%) | 1 ligoje |
| LAMA5laminin subunit alpha 5 | Kartais (5–29%) | 1 ligoje |
| LRP5LDL receptor related protein 5 | Kartais (5–29%) | 2 ligose |
| LSM11LSM11, U7 small nuclear RNA associated | Kartais (5–29%) | 1 ligoje |
| MAGI2membrane associated guanylate kinase, WW and PDZ domain containing 2 | Kartais (5–29%) | 1 ligoje |
| MAP3K20mitogen-activated protein kinase kinase kinase 20 | Kartais (5–29%) | 1 ligoje |
| MARCHF6membrane associated ring-CH-type finger 6 | Kartais (5–29%) | 1 ligoje |
| MSX2msh homeobox 2 | Kartais (5–29%) | 3 ligose |
| MT-TL2mitochondrially encoded tRNA-Leu (CUN) 2 | Kartais (5–29%) | 1 ligoje |
| MTHFRmethylenetetrahydrofolate reductase | Kartais (5–29%) | 1 ligoje |
| MYL2myosin light chain 2 | Kartais (5–29%) | 1 ligoje |
| MYO1Emyosin IE | Kartais (5–29%) | 1 ligoje |
| NAGSN-acetylglutamate synthase | Kartais (5–29%) | 1 ligoje |
| NOTCH2notch receptor 2 | Kartais (5–29%) | 1 ligoje |
| NPHS1NPHS1 adhesion molecule, nephrin | Kartais (5–29%) | 1 ligoje |
| NPHS2NPHS2 stomatin family member, podocin | Kartais (5–29%) | 1 ligoje |
| NPPAnatriuretic peptide A | Kartais (5–29%) | 1 ligoje |
| NR3C1nuclear receptor subfamily 3 group C member 1 | Kartais (5–29%) | 1 ligoje |
| NRASNRAS proto-oncogene, GTPase | Kartais (5–29%) | 1 ligoje |
| NUP107nucleoporin 107 | Kartais (5–29%) | 1 ligoje |
| NUP133nucleoporin 133 | Kartais (5–29%) | 1 ligoje |
| NUP160nucleoporin 160 | Kartais (5–29%) | 1 ligoje |
| NUP205nucleoporin 205 | Kartais (5–29%) | 1 ligoje |
| NUP37nucleoporin 37 | Kartais (5–29%) | 1 ligoje |
| NUP85nucleoporin 85 | Kartais (5–29%) | 1 ligoje |
| NUP93nucleoporin 93 | Kartais (5–29%) | 1 ligoje |
| PAX2paired box 2 | Kartais (5–29%) | 1 ligoje |
| PLCE1phospholipase C epsilon 1 | Kartais (5–29%) | 1 ligoje |
| PRORPprotein only RNase P catalytic subunit | Kartais (5–29%) | 1 ligoje |
| PRTN3proteinase 3 | Kartais (5–29%) | 1 ligoje |
| PTPROprotein tyrosine phosphatase receptor type O | Kartais (5–29%) | 1 ligoje |
| RACGAP1Rac GTPase activating protein 1 | Kartais (5–29%) | 1 ligoje |
| RAF1Raf-1 proto-oncogene, serine/threonine kinase | Kartais (5–29%) | 1 ligoje |
| RAPGEF2Rap guanine nucleotide exchange factor 2 | Kartais (5–29%) | 1 ligoje |
| RASA1RAS p21 protein activator 1 | Kartais (5–29%) | 1 ligoje |
| RETret proto-oncogene | Kartais (5–29%) | 1 ligoje |
| RHOBTB2Rho related BTB domain containing 2 | Kartais (5–29%) | 1 ligoje |
| RNASEH2Aribonuclease H2 subunit A | Kartais (5–29%) | 1 ligoje |
| RNASEH2Bribonuclease H2 subunit B | Kartais (5–29%) | 1 ligoje |
| RNASEH2Cribonuclease H2 subunit C | Kartais (5–29%) | 1 ligoje |
| RNF168ring finger protein 168 | Kartais (5–29%) | 1 ligoje |
| RNU7-1RNA, U7 small nuclear 1 | Kartais (5–29%) | 1 ligoje |
| SAMD12sterile alpha motif domain containing 12 | Kartais (5–29%) | 1 ligoje |
| SAMHD1SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 | Kartais (5–29%) | 1 ligoje |
| SAT1spermidine/spermine N1-acetyltransferase 1 | Kartais (5–29%) | 1 ligoje |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Kartais (5–29%) | 2 ligose |
| SCN5Asodium voltage-gated channel alpha subunit 5 | Kartais (5–29%) | 1 ligoje |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Kartais (5–29%) | 1 ligoje |
| SDHCsuccinate dehydrogenase complex subunit C | Kartais (5–29%) | 1 ligoje |
| SELENONselenoprotein N | Kartais (5–29%) | 1 ligoje |
| SLC1A3solute carrier family 1 member 3 | Kartais (5–29%) | 2 ligose |
| SOX5SRY-box transcription factor 5 | Kartais (5–29%) | 1 ligoje |
| SPP1secreted phosphoprotein 1 | Kartais (5–29%) | 1 ligoje |
| STOX1storkhead box 1 | Kartais (5–29%) | 1 ligoje |
| TBC1D8BTBC1 domain family member 8B | Kartais (5–29%) | 1 ligoje |
| TNRC6Atrinucleotide repeat containing adaptor 6A | Kartais (5–29%) | 1 ligoje |
| TPM2tropomyosin 2 | Kartais (5–29%) | 1 ligoje |
| TPM3tropomyosin 3 | Kartais (5–29%) | 1 ligoje |
| TREX1three prime repair exonuclease 1 | Kartais (5–29%) | 1 ligoje |
| TRPC6transient receptor potential cation channel subfamily C member 6 | Kartais (5–29%) | 1 ligoje |
| TWIST1twist family bHLH transcription factor 1 | Kartais (5–29%) | 1 ligoje |
| USP48ubiquitin specific peptidase 48 | Kartais (5–29%) | 1 ligoje |
| USP8ubiquitin specific peptidase 8 | Kartais (5–29%) | 1 ligoje |
| WT1WT1 transcription factor | Kartais (5–29%) | 1 ligoje |
| YEATS2YEATS domain containing 2 | Kartais (5–29%) | 1 ligoje |
| ZEB2zinc finger E-box binding homeobox 2 | Kartais (5–29%) | 1 ligoje |
| CASP10caspase 10 | Retai (1–4 %) | 1 ligoje |
| CLCNKBchloride voltage-gated channel Kb | Retai (1–4 %) | 1 ligoje |
| COL1A1collagen type I alpha 1 chain | Retai (1–4 %) | 1 ligoje |
| COL5A1collagen type V alpha 1 chain | Retai (1–4 %) | 1 ligoje |
| COL5A2collagen type V alpha 2 chain | Retai (1–4 %) | 1 ligoje |
| FASLGFas ligand | Retai (1–4 %) | 1 ligoje |
| SLC12A3solute carrier family 12 member 3 | Retai (1–4 %) | 1 ligoje |
| ANO1anoctamin 1 | Neužfiksuota | 1 ligoje |
| CYB5R3cytochrome b5 reductase 3 | Neužfiksuota | 1 ligoje |
| DNAI1dynein axonemal intermediate chain 1 | Neužfiksuota | 1 ligoje |
| MAOAmonoamine oxidase A | Neužfiksuota | 1 ligoje |
| TGFB1transforming growth factor beta 1 | Neužfiksuota | 1 ligoje |
| TTRtransthyretin | Neužfiksuota | 1 ligoje |
| VANGL1VANGL planar cell polarity protein 1 | Neužfiksuota | 1 ligoje |
| ZFHX2zinc finger homeobox 2 | Neužfiksuota | 1 ligoje |
Kaip dažnai šis požymis pasitaiko žmonėms, turintiems vieną iš geno sukeliamų ligų, ir kuris dažnis tarp jų didžiausias, pagal Žmogaus fenotipo ontologijos duomenis. Šiuose puslapiuose aprašomi požymiai ir juos grindžiantys tyrimai; tai nėra diagnozė, o su simptomais kreipkitės į gydytoją ar genetikos konsultantą.
Siauresni požymiai
Platesni požymiai
Iš kur tai žinoma
- Žmogaus fenotipo ontologija, 2026-09-01 leidimas: požymis, jo pavadinimai, apibrėžimas ir su juo susiję genai. Daugiau sužinokite svetainėje hpo.jax.org.
- Duomenų leidimas 2026.10.16-c6eea6bf.
Vienas testas. Atsakymai visam gyvenimui.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites